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Abstract
Background—Alzheimer’s disease (AD) is a neurodegenerative disease that results in severe 
disability. Very few studies have explored changes in daily physical activity patterns during early 
stages of AD when components of physical function and mobility may be preserved.
Methods—Patients with mild AD and controls (n=92) recruited from the University of Kansas 
Alzheimer’s Disease Center Registry, wore the Actigraph GT3X+ for seven days, and provided 
objective physical function (VO2 max) and mobility data. Using multivariate linear regression, we 
explored whether individuals with mild AD had different daily average and diurnal physical 
activity patterns compared to controls independent of non-cognitive factors that may affect 
physical activity, including physical function and mobility.
Results—We found that mild AD was associated with less moderate-intensity physical activity 
(p<0.05), lower peak activity (p<0.01), and lower physical activity complexity (p<0.05) 
particularly during the morning. Mild AD was not associated with greater sedentary activity or less 
lower-intensity physical activity across the day after adjusting for non-cognitive covariates.
Conclusions—These findings suggest that factors independent of physical capacity and mobility 
may drive declines in moderate-intensity physical activity, and not lower-intensity or sedentary 
activity, during the early stage of AD. This underscores the importance of a better mechanistic 
understanding of how cognitive decline and AD pathology impact physical activity. Findings 
emphasize the potential value of designing and testing time-of-day specific physical activity 
interventions targeting individuals in the early stages of AD, prior to significant declines in 
mobility and physical function.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative disease associated with loss of 
cognitive and physical function. Although cognitive symptoms are primary, studies have 
*Corresponding Author: Vijay R. Varma, 410-274-3561, vijay.varma01@gmail.com. 
HHS Public Access
Author manuscript
J Alzheimers Dis. Author manuscript; available in PMC 2018 March 20.
Published in final edited form as:













shown that walking difficulties and motor dysfunction are also common [1, 2]. These 
mobility impairments may have a common cause with cognitive decline [3] and may be 
closely associated with neurodegeneration and AD pathology AD, including gray matter 
degeneration, white matter damage, and amyloid-beta accumulation [4, 5].
Physical activities, including activities of everyday living (ADLs), leisure-time activities, 
and exercise, are dependent on mobility and cognitive functioning [3]. While very few 
studies have explored changes in physical activity during the early stages of AD, gross 
motor function and certain domains of cognition [6] are largely preserved, suggesting that 
many daily physical activities may also be maintained [7]. As AD progresses from the mild 
stage to more moderate and severe stages, declines in cognition and physical function lead to 
a significant reduction in physical activities due to the inability to function independently [7] 
and severe disability [8].
In addition to functional declines, AD is also associated with a breakdown of the normal 
sleep-wake or rest-activity cycle [9]. Sleep disturbance, reduced quality of sleep, and 
increased daytime sleep are common in AD [10, 11], and worsen gradually with increasing 
disease severity [12]. These disturbances may significantly impact total physical activity as 
well as diurnal patterns of physical activity across the day. These changes may also reflect 
neurodegenerative processes, indicating potential targets for modification through 
intervention.
The mild stage of AD is critical for physical activity interventions that have the potential to 
slow the disease course [13], reduce functional dependence, and increase quality of life [14, 
15]. Individuals with mild AD, compared to those with moderate and severe AD, may have 
the physical and cognitive capacity to engage in a broad range of activities, and may have 
more intact circadian rhythms. Thus, they are an important target group for interventions, 
including aerobic exercise [16] and multimodal interventions [17, 18] that have been shown 
to improve cognition and increase brain health.
Prior to testing these interventions, it is critical to better understand how physical activity 
may change due to mild AD when only subtle declines in physical function and mobility are 
observed [19, 20]. Very few studies have explored how mild AD may alter physical activity 
levels, and none have explored how physical activity patterns across the day are impacted. 
Considering changes in circadian rhythms due to AD, and the potential impact of those 
change on physical activity, it is critical to explore both daily average and diurnal patterns of 
activity, which may provide important insights for the design of tailored physical activity 
interventions.
We measured physical activity continuously for seven days using body-worn accelerometers 
in older adults with mild AD and cognitively normal older adult controls. We were interested 
in describing diurnal physical activity profiles among individuals with mild AD compared to 
controls to better understand how AD may affect physical activity in the earliest disease 
stage, independent of the effects of non-cognitive factors including physical function and 
age.
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Participants were recruited from the University of Kansas Alzheimer’s Disease Center 
Registry (KU-ADC), a large registry of well-characterized AD patients and older adult 
controls without cognitive impairment. KU-ADC recruitment and evaluation have been 
described previously [21]. Registry participants receive cognitive testing and clinical 
examinations annually. Experienced study clinicians trained in dementia assessment and 
clinical research provide consensus diagnoses through a comprehensive clinical research 
evaluation and review of medical records. Diagnostic criteria for AD follow NINCDS-
ADRDA criteria [22].
Participants who had undergone full physical and neurological examinations and a review of 
medical history were recruited into this study. The study sample included individuals with 
mild AD based on a clinical dementia rating (CDR; [23]) scale scores of 0.5 (very mild) or 1 
(mild) or older adult controls with CDR scores of 0 (normal). Participants with AD were 
required to have a study partner who spends at least 10 hours per week with the participant, 
who would be with the participant every day during the data collection procedures (detailed 
below). Participants with mobility disability, including those confined to a bed or wheel 
chair, as well as participants with sensory impairment, including those with inadequate 
visual or auditory capacity were excluded. The KU-ADC registry excludes individuals with 
active (<2 years) ischemic heart disease (myocardial infarction or symptoms of coronary 
artery disease) or uncontrolled insulin dependent diabetes mellitus.
A total of 100 community dwelling older adults with and without mild AD were recruited. 
Of those, N=92 had valid actigraphy data (n = 39 mild AD; n = 53 controls). Demographic 
details are in Table 1. The study protocol was approved by the KU Medical Center 
Institutional Review Board. Participants, and/or their legally acceptable representative, 
provided written, informed consent.
Physical activity measure
Body-worn accelerometers are designed to measure total physical activity, incorporating a 
variety of activities including ADLs (e.g., housework), lifestyle activities (e.g., walking for 
pleasure), and exercise. These measures indicate the total amount of movement across the 
period of data collection within an individual’s natural daily environment. In this study, total 
physical activity was measured using a hip-worn accelerometer (Actigraph GT3X+, 
Pensacola FL; Actigraph, 2012). The GT3x+ is a compact, light-weight, and unobtrusive 
triaxial accelerometer that has been validated across a range of community dwelling older 
adult samples [24]. Hip placement was chosen because this placement has greater sensitivity 
and specificity for measuring sedentary and low-intensity activities [25].
Participants were instructed to wear the unit on their dominant hip, secured by an elastic 
waist belt, 24 hours a day for seven days. Participants kept a wear-time diary used to 
determine compliance (identifying periods of device removal) as well as wake and sleep 
time. For participants with mild AD, study partners were asked to assist with completing the 
wear-time diaries and compliance as needed. After the data collection period, participants 
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attended a follow-up visit where they returned the monitors, reviewed activity logs and 
completed additional questionnaires and maximal oxygen consumption (VO2 max) testing 
(described below).
The data cleaning protocol followed a three-step process. First vector magnitude data across 
three axes (medio-lateral (front-to-back), antero-posterior (side-to-side), and vertical 
(rotational)) collected every second was aggregated into one minute data. A single, tri-axial 
composite metric, or average vector magnitude (VM) was calculated for every minute of 
aggregated data ( ;[26]). As opposed to any uni-axial metric, 
average, VM provides a proximal metric of total body movement over a minute. Second, we 
excluded any data collection days where participants reported removing the device, other 
than during sleep time and while bathing. Third, we utilized the wear and non-wear time 
classification algorithm developed by Choi et al (freely available as an R package; “Physical 
Activity” downloadable at http://www.r-project.org/) [27, 28]. Briefly, this algorithm 
identifies wear and non-wear time based on patterns of zero and non-zero counts within each 
24-hour period. We excluded all days with < 10 hours of wear time [29]. Participants 
provided on average 5.9 valid days of accelerometer data (range: 5–11 days).
As we were primarily interested in waking activity, or the activity phase of the daily diurnal 
cycle, accelerometry derived measures of physical activity were calculated during waking 
hours. Waking hours were defined as the interval of time between participant self-reported 
wake and sleep times recorded in wear-time diaries. Daily waking activity measures 
included daily averaged intensity metrics, and diurnal pattern metrics. Intensity metrics 
included amount of low-intensity and moderate-intensity activity per day, and number of 
minutes of sedentary activity per day. Intensity thresholds were based on previously 
published cut points for vector magnitude data derived from the Actigraph GT3X+ [30, 31], 
and included 0–149 counts/min for sedentary; 150–2689 counts/min for light-intensity; and 
2690+ counts/min for moderate- to vigorous-intensity.
Diurnal pattern metrics were developed to describe how activity changed over the day. 
Rather than fitting a traditional cosine model (which may not approximate diurnal activity 
rhythms, particularly among diseased groups [32]) and estimating standard parameters, we 
directly calculated the following metrics: peak activity, or the maximum activity/minute 
during waking hours, and time of peak activity, or the time at which the peak activity minute 
occurred. To explore fluctuations in physical activity over the day relative to average activity, 
we calculated the root mean square deviation (RMSD), or standard deviation of all minute-
to-minute physical activity intervals during waking hours. Prior evidence indicates that time 
dependent measures of variability, including RMSD, may provide an indication of an 
individual’s ongoing physical interaction with the environment including response to 
external demands [33]. This measure has also been previously used to measure the 
complexity of physiologic systems [33, 34], and indicates the extent to which an individual’s 
activity over a time period deviates from a flat, non-varying rhythm.
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Cardiorespiratory capacity, declines with age [35, 36], and is associated with the ability to 
complete ADLs and function independently [37]. Furthermore, the association between 
physical activity and cognition may be mediated by cardiovascular fitness [38]. We explored 
group differences in physical activity independent of cardiorespiratory capacity to better 
understand how AD may affect daily physical activity independent of the capacity to 
complete those activities. We measured maximal oxygen consumption, or VO2 max, by a 
graded treadmill exercise test using the modified Bruce protocol [39] designed for older 
adults. Briefly, participants began walking at a pace of 1.7 miles per hour at 0% incline; the 
grade and/or speed was increased at each subsequent two minute interval. Expired gases 
were collected continuously and oxygen uptake and carbon dioxide production were 
averaged at 15-second intervals (TrueOne 2400. Parvomedics, Sandy UT). VO2 max was 
calculated as the maximum milliliters of oxygen consumed in 1 minute per body weight in 
kilograms.
Variables that have also been shown previously to be associated with physical activity 
include body mass index (BMI), mobility impairment, age, sex, and race. We measured 
whole body mass using a digital scale accurate to ±0.1kg (Seca Platform Scale, Seca Corp., 
Columbia, MD), and height (in cm) was measured by stadiometer with shoes off—body 
mass index (BMI; weight (kg)/height (m2)) was then calculated from these measures. Self-
report measures, including physical function and mobility, age, sex, and race, were reported 
by either the participant or study partner. Physical function and mobility measures (Yes/No) 
included 1) Difficulty using stairs; 2) Physical difficulty getting around the house 
independently; and 3) Use of a walking aid (cane or walker). We generated a summary score 
for mobility impairment defined as “yes” to any of the three mobility impairment measures 
or “no” to all three measures. Mobility impairment was included as a binary variable (Yes/
No).
Statistical Analyses
We compared baseline physical function, mobility, and socio-demographic differences 
between the mild AD and normal control groups, with a particular emphasis on factors that 
have been previously shown to be related to physical activity, as detailed above. We included 
total physical activity at baseline for descriptive purposes. We used t-tests for continuous 
variables and chi-square tests for dichotomous variables. We confirmed associations 
between VO2 max and daily low-intensity, moderate-intensity, and sedentary activities (vm) 
using Pearson correlations. For descriptive purposes, we explored percentage of waking 
minutes spent in sedentary, light-, and moderate-intensity physical activity across the two 
groups. We log-transformed moderate-intensity physical activity (log vm) due to its skewed 
distribution. This transformed variable was used in subsequent analyses.
Our main objective was to explore differences in physical activity between participants with 
mild AD and controls, independent of non-cognitive factors that may drive differences in 
physical activity, including VO2 max. We used multiple linear regression to model the 
relationship between physical activity intensity and diurnal patterns (dependent variables) 
and the main predictor of interest, group status (mild AD vs control). We first modeled the 
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associations (Model 1) including covariates described above. Next, we explored the times of 
day when activity patterns between mild AD participants and controls diverged. We tested 
differences in physical activity metrics (Model 2) that were significant in Model 1 across the 
day, including the following time periods: morning (7:00am – 12:00pm), afternoon 
(12:00pm – 5:00pm), and evening (5:00pm – 10:00pm). Averaged participant self-reported 
wake (7:00 am) and sleep (10:00 pm) times were used to determine intervals for wake hours. 
These diurnal multivariate analyses included the same covariates used in Model 1. We 
plotted differences in physical activity over the day by group status to visualize results from 
Model 2. All statistical tests were two-sided and performed using Stata version 13 
(StataCorp. 2013 Stata Statistical Software: Release 13. College Station, TX: StataCorp LP). 
Regression diagnostics for outliers and normality of distributions were performed by visual 
inspection.
Results
Table 1 presents characteristics of the study sample, comparing Mild AD and control groups. 
Groups did not vary on the majority of covariates potentially related to physical activity 
including age, VO2 max, body mass index, and race. Groups did vary significantly by sex. 
Mild AD participants were majority male while control participants were majority female. 
Mild AD participants had lower total physical activity compared to control participants. This 
study sample was very well suited to exploring physical activity differences independent of 
V02 max and other covariates considering the lack of significant differences across the 
majority of relevant covariates.
Supplementary figure 1 indicates correlations between physical activity intensity metrics and 
VO2 max. As expected, all metrics were significantly associated with VO2 max (ps < 0.01), 
with the strongest correlation for moderate-intensity physical activity (r = 0.605; p < 0.001). 
Supplementary figure 2 describes percentage of waking minutes spent within each intensity. 
Both the mild AD and control groups spent less than 3.2% of waking physical activity in the 
moderate-intensity range; the majority of physical activity was in the sedentary and low-
intensity ranges.
Table 2 presents Model 1 results exploring differences in physical activity intensity and 
diurnal patterns by group (Mild AD vs control), controlling for covariates. Among intensity 
metrics, only moderate-intensity physical activity was significantly different between 
groups. Mild AD participants had less log vm daily moderate-intensity physical activity 
compared to controls. Among diurnal pattern metrics, peak activity and RMSD were both 
significantly different between groups. Mild AD participants had a lower peak activity. They 
also had a lower RMSD, a measure of physical activity complexity, compared to control 
participants suggesting that mild AD participants have less deviation from a flat, non-
varying rhythm.
Table 3 presents Model 2 results exploring differences in metrics significant in Model 1 by 
time of day. We found that for all physical activity metrics, differences were greatest during 
the morning period (7am – 12pm). During this period, Mild AD participants had lower log 
vm moderate-intensity physical activity, lower vm peak activity and lower RMSD. Mild AD 
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participants had lower vm peak activity in the afternoon but did not significantly differ from 
control participant on any metrics during the evening time period. We present plots of 
differences in moderate-intensity PA and peak activity by time period in Figures 1 and 2, 
which reflect results from Model 2. Figure 1 indicates that for moderate-intensity PA, 
individuals with mild AD have a unimodal diurnal shape, compared to a bimodal shape for 
controls, and show the greatest difference from controls in the morning. Figure 2 indicates 
that for RMSD, individuals with mild AD show the greatest difference during the morning, 
and have a generally flat pattern throughout the morning and afternoon followed by a 
decline in the evening. Controls show a gradually declining RMSD over the entire day with 
a peak at wake time.
Discussion
Our study compared daily patterns of physical activity in mild AD and a sample of 
cognitively normal older adults well-matched on non-cognitive factors that are strongly 
associated with physical activity including VO2 max. Independent of those factors, 
individuals with mild AD had significantly lower moderate-intensity physical activity, lower 
physical activity complexity (RMSD), and lower peak activity, particularly during the 
morning compared to cognitively normal controls. We did not find differences in low-
intensity physical activity or sedentary activity across the entire day. These findings suggest 
that despite having similar physical function and capacity, individuals within the early stage 
of AD, compared to controls, show declines in moderate-intensity physical activity. This 
emphasizes the importance of a better mechanistic understanding of how cognitive decline 
and AD pathology impact components of physical activity including intensity and diurnal 
patterns across the day. It also highlights the potential value of designing and testing 
physical activity interventions targeting individuals in the early stages of AD, prior to 
significant declines in mobility and physical function.
Significant differences in moderate-intensity physical activity, physical activity complexity, 
and peak activity suggest that individuals with mild AD participate in less physically 
demanding and less physically complex activities particularly in the morning. Prior evidence 
indicates that cognitive decline and AD are associated with constricted life space and greater 
time spent at home [40]; Individuals with mild AD may spend less time in complex 
environments outside the home that may be more conducive to higher intensity physical 
activities [41, 42]. Our findings indicate that differences in moderate-intensity physical 
activity levels are not driven by differences in aerobic capacity (VO2 max), BMI, or other 
physical factors that may limit activity. This suggests that cognitive decline in the early stage 
of AD may limit physical activities particularly within the moderate-intensity range. Many 
moderate physical activities (e.g., dancing, mowing the lawn, sports, heavy cleaning) may be 
both more physically demanding and more cognitively complex than lower-intensity 
physical activities (e.g., sweeping, watering plants) and therefore may be more challenging 
for individuals with mild AD. These individuals may also be more cognitively dependent on 
a caregiver or other adult to facilitate or plan morning activities such as self-care or travel 
outside the home. However, the morning period may be the time of day when individuals 
with AD are the most alert [9, 43]. Therefore, the declines we observed in physical activity 
during this time period may be successfully buffered by well-designed interventions.
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While moderate-intensity physical activity differed significantly between groups, low-
intensity and sedentary activity, which comprised greater than 95% of daily waking activity, 
were not significantly different between the mild AD and control groups. This is consistent 
with evidence indicating that many daily activities may be preserved during the earliest stage 
of AD [7], and suggests that cognitive decline early in the disease course may not affect the 
majority of daily physical activities. Prior evidence indicates that sedentary behavior is 
associated with cognitive and physical function decline [44], and achievable and modest 
increases in physical activity within the low-intensity range may have health benefits [45–
47]. Results of this study suggest that individuals with mild AD are an important target 
group for low-intensity physical activity interventions that modestly increase daily physical 
activity and reduce sedentary time. Future research should consider implementing 
multimodal low-intensity physical activity interventions (e.g., [17, 18]) that include both 
social and cognitive components and have been appropriately modified for individuals with 
cognitive decline.
While evidence suggests that fragmented sleep, daytime napping and other circadian 
disruptions are common in AD [9], less is known about how those disruptions may affect 
daily physical activity patterns, intensity, and peak activity times. This is one of the first 
studies to our knowledge to explore how physical activity during waking hours may be 
affected by mild AD. Future studies should bridge disciplines focused on circadian rhythms 
with physical activity to better understand how changes to the sleep-wake cycle may be 
associated with physical activity decline and how AD pathology may influence both.
This study has several limitations. First, the use of a hip worn accelerometer excludes certain 
physical activities, including swimming, cycling, and upper body activities, and may 
therefore underestimate total physical activity. Second, because the study is cross sectional, 
we cannot draw causal conclusions about the effect of mild AD on physical activity. While 
our study suggests that physical activity differences are not driven mainly by physical factors 
associated with mild AD, we did not directly test the hypothesis that cognitive or brain 
changes may be responsible. It is also possible that group differences in structural factors 
(i.e., neighborhood characteristics, presence of a caregiver) and psychological characteristics 
(i.e., self-efficacy, depressive symptoms) may contribute to results. Future longitudinal and 
mechanistic studies building on this work will help us better understand how cognitive 
decline and brain pathology associated with AD may directly impact patterns of physical 
activity. This study has a number of strengths including a study design that allowed us to 
specifically explore physical activity differences associated with mild AD in two groups 
approximately matched on VO2 max, age, and other non-cognitive factors associated with 
physical activity. We compared both intensity and diurnal pattern metrics derived from 
objective measures of physical activity that went beyond total average activity to more 
specifically characterize daily physical activity differences between groups. These analytic 
methods provide a more detailed profile of how physical activity may decline during early 
stages of the disease. Future studies exploring physical activity declines and physical activity 
interventions among individuals with AD should consider measuring diurnal variations in 
physical activity.
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This study is among the first to use objective measures of physical activity and physical 
function to explore physical activity in the early stages of AD. Results provide support for 
exploring the effects of specifically timed physical activity interventions across intensities 
that may help slow the disease course and preserve independent function among AD 
patients.
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Mean (SD) Mean (SD) Mean (SD)
Age (years) 73.5 (7.9) 73.2 (6.5) 73.4 (7.1)
VO2max (ml/kg/min) 21.6 (5.2) 22.2 (5.4) 22.1 (5.3)
Body Mass Index 27.3 (5.0) 26.4 (4.1) 26.8 (4.5)






N (%) N (%) N (%)
Mobility impairment (% indicating any impairment) 6 (10.5%) 4 (11.3%) 10 (11.0%)
Female* 11 (28.2%) 37 (69.8%) 48 (52.2%)
Race (% white) 34 (87.2%) 51 (96.2%) 85 (92.4%)
Difference between Mild AD and Control:
*
p < 0.01
SD = standard deviation; V02max = maximal oxygen consumption; ml/kg/min = milliliters of oxygen per kilogram of body mass per minute; vm = 
vector magnitude


















(Mild AD - Control) SE p-value
Intensity
Low-intensity PA (vm) −39,538.380 28,931.13 0.176
Moderate-intensity PA (log vm) −0.679* 0.299 0.026
Sedentary minutes −5.738 26.691 0.830
Diurnal pattern
Peak activity (vm) −753.129** 264.279 0.006
Time of peak activity (min) 59.877 36.284 0.103





p < 0.01; all models included the following covariates (in addition to group status): body mass index (BMI), age, race, V02 max, and mobility 
impairment.
PA = physical activity; vm = vector magnitude; β = beta coefficient from multiple regression model; SE = standard error; min = minutes; RMSD = 
root mean squared deviation
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